Seems no longer double or triple for net profit.
Not even 50%.
The days of extraordinary profit is over.
Looks like net profit for Supermax will normalise soon starting with next quarter.

There is always institutional short sellers waiting on the sidelines especially in the mature stock market cycle.

Tony Fernandes initially plan back in October 2020 was looking the borders to open for flights in March 2021.

Looks like his plans is delayed at least till December 2021.

How much can the company continue to bleed on daily overhead fixed cost?

@Ben Tan

I believe the world largest glove manufacturer refers to the number of glove production capacity instead of market capitalization.

Topglove is the largest and is currently meeting 25% of world demand.

@Ibelieve

The pandemic is still not under control but numbers worldwide in the last 1-week had been improving. You may check number of new cases and death rate country by country starting with US, UK, Africa and Asia.

The worst of all Spanish Flu in 1918 which claimed 50 million lives took 2-3 years to recover.

Science and technology to produce vaccine had improved in the last 100 years.

So you can roughly estimate when Covid-19 will likely start to recover.

Though Topglove's ESG rating is quite horrible at this moment, there are other glove makers which are much better eg: Hartalega or Supermax.

I believe the investing community should temporary boycott TOPGLOVE and shift your investment to other glove makers and make a stand that we only support companies that treat their employees well.

Expecting good quarter result next week TSMC is also running at maximum capacity since last quarter to meet world demand.

Unprecedented under value but offer downgrade TP from RM9.50 to RM8.45.
A foolish analyst indeeed.

All the best to you Uncle.
I feel for you at 88 years old, still holding losses in stocks.

Inari is lagging when comparing with Unisem.

Besides that, Inari has superior earnings and revenue over Unisem in the last 5-year.

Inari PE is half of Unisem.

Likely much more upside for Inari moving forward

Looks very unlikely.

A normal scene for privatization will be mopping up own shares when price is at the lowest. The recent scenario in 2020 is CCM.

If Neogenix can provide more than extraordinary profit during this pandemic, why would the selling shareholder,Neoh Cheu An want to give up his 60% stakes for RM6.5 million to Hong Seng.
Something fishy here.

Hopefully, the IDSS will be further extended to 31/12/2021.
Else may be a setback to glove and many other stocks.

Any idea whether building solar panels will be impacted during MCO ?
Are they essentiall?

Title mentioned ASP to rise in Jan and Feb 2021, but TP remains lower than TP in 2020.
The analyst doesn't even believe himself.

5G is the theme for 2021-2025
It would a new catalyst for Inari moving forward as more phones utilize more RF

Wait for the 11am news to know more about the impact on businesses.

Good opportunity for Frontken to be participate in TSMC new plant in US.

KYY, had officially made paper loss over 30%.
A first for him?

It's logical for Supermax to continue weaknesses in this efficient stock market.
Today information are widely available unlikely in the early 80s and 90s.
Thus, today investors, speculators and day traders have updated information in their hands at any time, thus making trading decision more effectively.
I believe vaccine is the Achilles heel for glove.

To KYY, there are many books you can read about the efficiency of today's stock market worldwide. Spend more time reading and learning rather than blogging.

KYY paper loss in Supermax had already exceed 20%
My advice to him is to keep the stock long term eg: 5 years to see the reward.
Writing more blogs will not help much but only to reflect his frustrations.
Glove counters will still provide much fundamental and good return over the next decade.
Will he live to see it.
That's why it's not advisable for anyone above 60 to invest in stocks.
60s and above is the best time to enjoy the fruits of your investment when you are young.

Probably less selling pressure as most traders, investors, etc are leaving for this holiday season.
They should be back on 4/1/2021

I think the best valuation for glove counters is post Covid-19 and after 2024 where demand is expected normalise, though still much higher then pre-Covid-19.
My take is pre-covid-19 , world demand is approximately 260 bil per annum in 2019
Post Covid-19, world demand should be somewhere between 350 bil to 370 bil per annum in 2024 onwards.

Supply side by 2024 from Top 5 largest and small players worldwide may come in between 110-130 bil per annum.

Based on this estimation, demand will almost offset the large incoming supply in 4 years time. Possible small oversupply of 20bil-25 bil per annum which may cause ASP to normalise toward USD35-USD45 level which is 50%-80% higher pre-covid 19 ASP.

I disagree.
I believe charting is as important as financial analysis.
Using both method yielded impressive results for me.

@gongkia

https://klse.i3investor.com/blogs/koonyewyinblog/2020-11-17-story-h1536464770-Supermax_is_the_most_underrated_glove_stock_Koon_Yew_Yin.jsp

Average price of supermax on 16/11/2020 is RM8, 1 day before he post this blog

KYY re-entered price is above RM8.
He's making losses already.

I still don't get it why ppl are still debating on glove vs vaccine, sell or buy glove.

Get a life all of you.

Know your investment principle that had been perfected, ignore the noises, buy or sell whatever stock as you see fit.

No justification required because you are the specialist in your investment.

At the end of the day, your portfolio grows or shrinks, look at yourself in the MIRROR, the answer lies there.

Buy a stock based on your understanding not from others.
Learn to do your own valuation and be good at it.
Prove to others than you do not require to follow the herd.
Buy or sell at your own judgement as it is your own hard earned money.
Unless somehow, you received a large donation of USD600 mil.

Not a glove maker yet

'To be' glove maker

@KYY
Higher EPS of Supermax does not mean, the company is better than Hartalega , Topglove or Kossan.

Factors such as no of share issued is also a consideration. Topglove issued more shares which has a larger denominator than Supermax, thus the lower EPS.
If Topglove has the same no of shares issued as Supermax, the current EPS would be more than RM1.0.

Rather the focus should be the company's annual net profit

Actually back then before CNY 2020, Supermax was trading at lower PE of 12 as compared its peers: Topglove (pe=30), Kossan (pe=25), Harta (pe=45)

It's more like investor began to see that it's undervalued and the PE now is reflecting better than previously.

Define better?

1QFY2021 will be released on 09 December 2020

https://www.topglove.com/corporate-calendar/

Topglove: What will Topglov be reporting Q3 profit?


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-18-story-h1536493634-Topglove_What_will_Topglov_be_reporting_Q3_profit.jsp

Topglove: What will Topglov be reporting Q3 profit?


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-18-story-h1536493634-Topglove_What_will_Topglov_be_reporting_Q3_profit.jsp

Topglove: What will Topglov be reporting Q3 profit?


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-18-story-h1536493634-Topglove_What_will_Topglov_be_reporting_Q3_profit.jsp

Topglove: What will Topglov be reporting Q3 profit?


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-18-story-h1536493634-Topglove_What_will_Topglov_be_reporting_Q3_profit.jsp

Topglove: What will Topglov be reporting Q3 profit?


https://klse.i3investor.com/blogs/20200913StoryRM200Bil/2020-11-18-story-h1536493634-Topglove_What_will_Topglov_be_reporting_Q3_profit.jsp

for those in 10th floor, I suggest keep the stock, enjoy the company's large expansion to 40++ bil glove production in 2 years, get rewarded with dividends and bonus issues in the future if you believe the company's long term growth.

Unless, you have desperate need to use the money you had put into this counter.

Good write up.
Simple and on the spot.
It's really up to individual investor to decide their entry & exit.
Long term investors > 5 years normally do well.

Unlike KYY who is not an investor as he seems more like a trader which I do not recommend as there is volatility in the short term nature of glove stocks and pharma stocks.

Whoever prefers to buy vaccine, buy pharma related counters
Whoever prefer gloves, buy glove counters.
Whoever think both are good, buy both pharma and gloves
Whoever think both are over, sell everything

I don't see the point of arguing over it.

Topglove had updated the CBP status in the annual report on 12/11.

Dividends had been declared on 23/9 and paid on 3/11.

Which part you are not clear?

https://de.reuters.com/article/us-health-coronavirus-vaccines-distribut/why-pfizers-ultra-cold-covid-19-vaccine-will-not-be-at-the-local-pharmacy-any-time-soon-idUSKBN27P2VI

Pfizer vaccine needs to be at minus 70-80 degrees celcius

Yusen Gold Cold can handled up to minus 20 degrees celcius


https://www.yusen-logistics.com/en/industries/healthcare-logistics/

Our capabilities include dedicated and managed fleets with temperature-control capabilities and secure GDP compliant temperature controlled hubs. These controlled temperature (15–25°C), cold storage (2–8°C) and frozen storage (<–20°C) facilities allow us to offer warehouse capacity for a range of pharmaceutical and biopharmaceutical products.

https://de.reuters.com/article/us-health-coronavirus-vaccines-distribut/why-pfizers-ultra-cold-covid-19-vaccine-will-not-be-at-the-local-pharmacy-any-time-soon-idUSKBN27P2VI

Pfizer vaccine needs to be at minus 70-80 degrees celcius

Yusen Gold Cold can handled up to minus 20 degrees celcius


https://www.yusen-logistics.com/en/industries/healthcare-logistics/

Our capabilities include dedicated and managed fleets with temperature-control capabilities and secure GDP compliant temperature controlled hubs. These controlled temperature (15–25°C), cold storage (2–8°C) and frozen storage (<–20°C) facilities allow us to offer warehouse capacity for a range of pharmaceutical and biopharmaceutical products.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3097777

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3097777

Expected this to happne when you rush to develop this vaccine in 6 months which normally takes at least 2-3 years and some 4-5 years.

I'm fairly confident that after the vaccine is developed, very few ppl will want to be vaccinated as they are afraid of the unknown adverse affects of it.

Just like software release of Alpha/Beta version, most ppl would wait for the official release.

Ask yourself a question where Supermax will be 10 years from now.

@Steve Ooi

It's President Biden's mandate during his election campaign to procure PPE using his Executive Order.

https://www.cnbc.com/2020/10/23/joe-biden-lays-out-a-detailed-plan-to-fight-coronavirus-.html

@Airline Bobby

You're another individual negative of glove based on all your comments.
I'm publishing based on facts and I did not give a timeline as no one knows.

One key point for sure is WRP Asia case took 6 months to revoke, thus is a good benchmark since Topglove had engaged the same consultant that helps WRP Asia to solve the same issue.